Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score

The Oncotype DX(®) recurrence score (RS) predictor has been clinically utilized to appropriately select adjuvant chemotherapy for patients with estrogen receptor (ER)-positive early breast cancer. However, the selection of chemotherapy for patients with intermediate RSs remains controversial. We ass...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ahn, Sung Gwe, Lee, Hak Min, Lee, Hak Woo, Lee, Seung Ah, Lee, Se-Ra, Leem, Sun-Hee, Jeong, Joon, Chu, In-Sun
Formato: Artigo
Idioma:Inglês
Publicado em: Molecular Diversity Preservation International (MDPI) 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3876071/
https://ncbi.nlm.nih.gov/pubmed/24304542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms141223685
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados